•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Buy 2 Ideal June DiviDogs Per Barron's April To June Picks
Are Investors Undervaluing ADT (ADT) Right Now?
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
ADT (ADT) Upgraded to Buy: Here's Why
ADT Announces Yet Another DIY Home Security Line, Now With AI Features
ADT Has A Clear AI-Driven Future (Rating Upgrade)
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer
Is ADT (ADT) Stock Undervalued Right Now?
Newsweek Recognizes ADT As Top Home Security Brand in America This Year
Stock Market Today, May 4: ADT Falls as Apollo Exits Stake Through 102 Million-Share Offering
ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
ADT Inc. (ADT) Q1 2026 Earnings Call Transcript
ADT Reports First Quarter 2026 Results
Should Value Investors Buy ADT (ADT) Stock?
4 Stocks to Gain From the Thriving Security and Safety Industry
ADT to Release First Quarter 2026 Results on Thursday, April 30
ADT Evolves Smarter Protection Beyond Your Front Door
Are Investors Undervaluing ADT (ADT) Right Now?
SG Americas Securities LLC Buys New Position in ADT Inc. $ADT